Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
Keyword(s):
This is a single-center retrospective observational cohort study comparing daptomycin/ceftaroline combination therapy with rifampin-adjunct therapy for the treatment of staphylococcal device infections. The results of this study support use of the daptomycin/ceftaroline as an alternative or salvage option to standard of care.
2018 ◽
Vol 24
(12)
◽
pp. 965-968
◽
2019 ◽
Vol 13
(3)
◽
pp. 279-286
◽
2018 ◽
Vol 51
(6)
◽
pp. 810-820
◽
2013 ◽
Vol 43
(12)
◽
pp. 796
◽
2020 ◽
Vol 6
(1)
◽